RDHL Exercise Disclosure
Raday Gilead · SEC Form 4 · Filed Oct 6, 2026
Exercise
Calculated transaction value
$0
Raday Gilead Chief Operating Officer
RDHL
Transaction date
Oct 1, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 5 days later
RDHL daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- American Depository Shares on Ordinary Shares
- Quantity / price
- 27,560,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001178913-26-004715
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$1.43K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Redhill Biopharma Ltd. RDHL | Sale | Oct 1, 2026 | $1.43K |
| Redhill Biopharma Ltd. RDHL Current | Exercise | Oct 1, 2026 | $0 |